Opioid Bills in the Senate: Focus on Medicare and OTPs by Alison Knopf Addiction Treatment Forum August 6, 2018 Excerpts: “This is a national crisis, and legislation has bipartisan support,” former Speaker Newt Gingrich told AT Forum last month. “Both ethically and politically, Congress has to pass a bill,” said Mr. Gingrich, who is also an advisor to Advocates for Opioid Recovery (AOR). “I think it
Telemedicine’s Role in Combating the Opioid Epidemic The lack of sufficient federal funding, coupled with the patchwork coordination of federal, state, and local authorities, has allowed the opioid crisis to reach epidemic proportions. Furthermore, many of the hardest hit areas are extremely rural or areas that have been impacted in recent years by various economic forces (e.g. inflation, recession). Consequently, many of the areas most affected
VIDEO: Opioid Crisis Spurs Demand for Telehealth Options The promise of telehealth has been talked about for years, with little fruition. The opioid crisis is changing that. Rural areas have been hit particularly hard by the crisis. Brick-and-mortar clinics aren’t popping up overnight, rural providers are being stretched thin, and opioid patients still need access to care. A video interview with Anne Woodbury, executive director of Advocates for Opioid
As Congress moves to vote on more than 50 bills responding to the opioid crisis, AOR urges legislators to support policies that would expand access to evidence-based treatment for opioid use disorder. Advocates for Opioid Recovery encourages policymakers to emphasize recovery services as they consider legislation over the next two weeks. Specifically, AOR asks legislators to: expand evidence-based treatment capacity enforce parity and break down barriers
AOR Statement of Support for “The Truth About Opioids” Advocates for Opioid Recovery (AOR) applaud the White House Office of National Drug Control Policy’s most recent efforts to address the ongoing public health emergency caused by opioid epidemic. Today, in partnership with the Truth Initiative and the Ad Council, the Administration unveiled the first set of public awareness ads meant to combat the opioid crisis. AOR
Advocates for Opioid Recovery Advisor Newt Gingrich Releases Blueprint for Addressing the Opioid Crisis
Gingrich’s New Book Devotes Significant Attention to Evidence-Based Solutions, Including Medication-Assisted Treatment Advocates for Opioid Recovery (AOR) advisor former House Speaker Newt Gingrich is releasing a new book this week, Trump’s America, in which he discusses the ongoing opioid epidemic and the handful of solutions that will make a significant difference in the lives of all Americans touched by addiction. Speaker Gingrich has been a steadfast proponent
Our #LetsTrumpAddiction social media campaign to encourage President Trump to reaffirm his commitment to ending the opioid crisis in his Joint Session speech to Congress is a winner! Thanks to your tireless advocacy, this campaign has won two incredible awards.
Advocates for Opioid Recovery partnered with the American Telemedicine Association to host a panel at ATA 2018. With the opioid overdose epidemic claiming more than 175 lives every day, America is facing a dire public health crisis unlike any our generation has ever seen. Every sector of society – from the government to the healthcare system and the private sector – is feeling the effects of
Advocates for Opioid Recovery Statement in Response to President Trump’s Opioid Initiative Advocates for Opioid Recovery (AOR) firmly believes that in order to save lives and combat the opioid epidemic in America, we must work together at all levels to break down barriers to addiction treatment. Five months after President Trump announced that he would declare the opioid epidemic a national public health emergency, we are
AOR signs on to group letter urging the U.S. Senate to correct the law that will help to ensure equal access to FDA approved treatment options
AOR signs on to group letter to urging the US Senate to correct the law that will help to ensure equal access to FDA approved treatment options.